PPN or PPD, what is the target for deep brain stimulation in Parkinson's disease?

scientific article published on 22 June 2007

PPN or PPD, what is the target for deep brain stimulation in Parkinson's disease? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/BRAIN/AWM138
P8608Fatcat IDrelease_t5kjeioc2fabpcuoi7miyazqcy
P698PubMed publication ID17586558
P5875ResearchGate publication ID6249967

P50authorJérôme YELNIKQ67222445
P433issuePt 9
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
deep brain stimulationQ618076
P304page(s)e79; author reply e80
P577publication date2007-06-22
P1433published inBrainQ897386
P1476titlePPN or PPD, what is the target for deep brain stimulation in Parkinson's disease?
P478volume130

Reverse relations

cites work (P2860)
Q35706455Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism
Q43073724Computational modeling of pedunculopontine nucleus deep brain stimulation.
Q81034320Deep brain stimulation for Parkinson's disease
Q37350392Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Q27021464Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?
Q48909041Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson's disease
Q47417202Functional parcellation of the lateral mesencephalus.
Q42486377Internal pallidum and substantia nigra control different parts of the mesopontine reticular formation in primate
Q38913945Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: proof of concept and histological correlation
Q42486566Neurophysiological evaluation of the pedunculopontine nucleus in humans
Q38161537New targets for deep brain stimulation treatment of Parkinson's disease
Q38023268Normal and pathological gait: what we learn from Parkinson's disease
Q34795347Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets
Q26852043Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?
Q35080746Pedunculopontine nucleus area oscillations during stance, stepping and freezing in Parkinson's disease
Q45946317Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review.
Q47839448Pedunculopontine nucleus microelectrode recordings in movement disorder patients
Q31131953Physiology of freezing of gait
Q38426047Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility
Q37892979Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?
Q26823204Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches
Q47581520Targeting of the pedunculopontine nucleus by an MRI-guided approach: a cadaver study
Q48547786The deep brain stimulation of the pedunculopontine tegmental nucleus.
Q37841286The deep brain stimulation of the pedunculopontine tegmental nucleus: towards a new stereotactic neurosurgery
Q34565674The effects of deep brain stimulation on sleep in Parkinson's disease.
Q37819451The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation
Q37824831The pedunculopontine nucleus as a target for deep brain stimulation
Q48428197Unilateral pedunculopontine stimulation improves falls in Parkinson's disease

Search more.